Biotech Stocks
Related articles
14/09/2021
MGC Pharmaceuticals Shares Lift on Landmark UK Import Permit (ASX:MXC)
MGC Pharmaceuticals said this marks the first time an epilepsy treatment containing THC and still undergoing clinical trials was approved by UK authorities for import. The news saw MGC Pharmaceuticals [ASX:MXC] shares jump 10% at the time of writing.
13/09/2021
Hazer Share Price Sinks on $7 Million Capital Raise Update (ASX:HZR)
The Hazer Group [ASX:HZR] share price sinks as the hydrogen tech developer completes a $7 million placement. Hazer will also invite eligible shareholders to participate in a share purchase plan to raise up to $7 million.
10/09/2021
Rhinomed Share Price Surges 20% on Government Deal (ASX:RNO)
The Rhinomed [ASX:RNO] share price is soaring this morning after the Victorian Department of Health placed initial orders for one million Rhinoswabs for SARS-CoV-2 testing.
01/09/2021
Imugene Share Price Sink 7% after Flagging Three New Trials (ASX:IMU)
The Imugene [ASX:IMU] share price is floundering today on the back of an announcement regarding its HER-Vaxx immunotherapy in HER-2 positive gastric cancer trial.
01/09/2021
7% Up For Immutep Share Price — Progresses Clinical Trials (ASX:IMM)
Small-cap biotech stock Immutep Ltd [ASX:IMM] is on the up today. The IMM share price is currently trading 7.92% higher at time of writing...
31/08/2021